ResMed (RMD) PT Lowered to $290 at KeyBanc
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $218.27 -0.6%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
KeyBanc analyst Brett Fishbin lowered the price target on ResMed (NYSE: RMD) to $290.00 (from $302.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- GMR Solutions to reprice $2.9B term loan, pay down $200M in debt
- Northrop Grumman wins two U.S. defense contracts worth $38.7m
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
KeyBanc, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
